psychotic disorders. Age-and gender-matched controls were identified from the Population Information System (n=62). The participants were administered a broad neuropsychological assessment, part of which was the Hinting Task assessing ToM. With 10 short discussions in everyday situations, the Hinting Task assesses the ability to conclude, from indirect speech, what another person really means. A factor score of the Hinting Task was formed, taking into account the varying difficulty level and relevance of the 10 items. To investigate the association between ToM and general cognitive functions, we summarized non-social cognitive performance constructing a "g factor", which was used as an overall index of general cognitive performance. Results: The internal consistency of the Hinting Task calculated from the dichotomized data was modest, with McDonald's categorical omega estimated at .57 (95 % CI .36, .71). In the single dimensional factor solution, items 8 and 9 had the weakest loadings and item 10 the strongest. Items 9 and 10 of the Hinting Task were the easiest, and items 1 and 8 were the most difficult. Participants with FEP (mean score 16.0) performed worse than controls (mean score 17.4) on the Hinting Task (Cohen's d=0.50 calculated from factor scores). However, the difference between FEP and control groups was no longer significant when general cognition was controlled for. 75 % of the variance between the groups was explained by general cognitive deficits, especially impaired processing speed (WAIS-III Digit Symbol) and episodic memory (WMS-III Logical Memory). When the FEP group was divided according to diagnosis, those with schizophrenia scored lower on the Hinting Task than the other psychosis patients. The ToM difference between individuals with schizophrenia and controls (Cohen's d=1.1) remained significant even when general cognitive performance was controlled for. In contrast, those with other psychotic disorders than schizophrenia did not differ from controls. ToM performance of the best functioning patient group (20 patients who had a GAF score ≥50, Hinting Task mean score 17.8) did not differ from that of the control group. Discussion: Based on this study, and supporting previous findings (Bora & Pantelis, Schizophr. Res. 2013), deficits in ToM were already present in early psychosis. They were largely overlapping with deficits in general cognitive processes. However, and in line with previous meta-analytical findings (Sprong et al., Br. J. Psychiatry 2007), in a subgroup of the FEP patients with schizophrenia, impairments in ToM remained after controlling for overall cognitive functioning. In conclusion, specific deficits in ToM could be found in schizophrenia, independent from general cognitive deficits. (Jardri et al. (2017). Nat Commun, 8:14218). The model suggests that during information integration of prior beliefs and sensory evidence, patients tend to put too much weight on the sensory evidence and to take it into account multiple times (over-count) compared to healthy individuals. An imbalance in excitatory/inhibitory regulation of hierarchical neural processing has been suggested to cause of this phenomenon (Jardri et al., 2017). Here, we investigated whether circular inference could
psychotic disorders. Age-and gender-matched controls were identified from the Population Information System (n=62). The participants were administered a broad neuropsychological assessment, part of which was the Hinting Task assessing ToM. With 10 short discussions in everyday situations, the Hinting Task assesses the ability to conclude, from indirect speech, what another person really means. A factor score of the Hinting Task was formed, taking into account the varying difficulty level and relevance of the 10 items. To investigate the association between ToM and general cognitive functions, we summarized non-social cognitive performance constructing a "g factor", which was used as an overall index of general cognitive performance. Results: The internal consistency of the Hinting Task calculated from the dichotomized data was modest, with McDonald's categorical omega estimated at .57 (95 % CI .36, .71). In the single dimensional factor solution, items 8 and 9 had the weakest loadings and item 10 the strongest. Items 9 and 10 of the Hinting Task were the easiest, and items 1 and 8 were the most difficult. Participants with FEP (mean score 16.0) performed worse than controls (mean score 17.4) on the Hinting Task (Cohen's d=0.50 calculated from factor scores). However, the difference between FEP and control groups was no longer significant when general cognition was controlled for. 75 % of the variance between the groups was explained by general cognitive deficits, especially impaired processing speed (WAIS-III Digit Symbol) and episodic memory (WMS-III Logical Memory). When the FEP group was divided according to diagnosis, those with schizophrenia scored lower on the Hinting Task than the other psychosis patients. The ToM difference between individuals with schizophrenia and controls (Cohen's d=1.1) remained significant even when general cognitive performance was controlled for. In contrast, those with other psychotic disorders than schizophrenia did not differ from controls. ToM performance of the best functioning patient group (20 patients who had a GAF score ≥50, Hinting Task mean score 17.8) did not differ from that of the control group. Discussion: Based on this study, and supporting previous findings (Bora & Pantelis, Schizophr. Res. 2013), deficits in ToM were already present in early psychosis. They were largely overlapping with deficits in general cognitive processes. However, and in line with previous meta-analytical findings (Sprong et al., Br. J. Psychiatry 2007) , in a subgroup of the FEP patients with schizophrenia, impairments in ToM remained after controlling for overall cognitive functioning. In conclusion, specific deficits in ToM could be found in schizophrenia, independent from general cognitive deficits. (Jardri et al. (2017) . Nat Commun, 8:14218) . The model suggests that during information integration of prior beliefs and sensory evidence, patients tend to put too much weight on the sensory evidence and to take it into account multiple times (over-count) compared to healthy individuals. An imbalance in excitatory/inhibitory regulation of hierarchical neural processing has been suggested to cause of this phenomenon (Jardri et al., 2017). Here, we investigated whether circular inference could be extended to describe the integration of sensory information and socially acquired information and whether the specific information integration style could contribute to the characteristic symptomatology and the social impairments seen in the disorder. Methods: Thirty-five patients with schizophrenia or schizo-affective disorder and 40 matched healthy controls performed the task. Participants had to guess the color (red or green) of the next marble to be drawn from a hidden urn based on information from their own sample (eight marbles) and the choices and confidence (high or low) of four other people. We fitted and comparatively assessed four multilevel Bayesian models (generalized linear model, simple Bayes, weighted Bayes, circular inference) describing how patients and controls integrated information. Positive and negative symptom severity and social functioning were also assessed. Results: The circular inference model best described the information integration in both patients and controls (WAIC weight = 1). Patients tended to over-weigh (β = 0.48, 95% CI: 0.30; 0.62) and over-count (β = 0.30, 95% CI: 0.12; 0.47) sensory information and under-weigh (β = -0.29, 95% CI: -0.42; -0.13) and under-count (β = -0.23, 95% CI: -0.35; -0.06) social information compared to controls. Crucially, this varied with symptomatology: the higher the symptom severity, the more over-counting and the higher the weight on sensory information and the more under-counting and the less weight on social information. More weight on social information was associated with higher level of functioning in the patients (β = 0.88, 95% CI: 0.01; 3.73). Discussion: All participants integrated social and sensory information in a non-linear fashion. Patients displayed a distinctive tendency to rely more and less discriminatively on sensory than on social information. This information integration style may contribute to the characteristic symptoms and the social impairments in schizophrenia. Background: Schizophrenia is associated with broad range of phenomena which affect function and represent significant barriers to recovery. These include semi-independent forms of psychopathology, disturbances in neurocognition, social cognition and metacognition. The current study explores the paths through which these constructs affect each other and whether some of these phenomena play a relatively more or less central role than others as they interact. Answers to these questions seem essential to choosing which of a dizzying array of problems should be targeted by treatment. Methods: Data was collected from 81 adult outpatients with schizophrenia or schizoaffective disorder, recruited at a Veterans' Affairs Medical Center and a community mental health center in Indiana, USA. Network analysis which explored the relative relationships of five groups of symptoms (positive, negative, disorganization, hostility and emotional discomfort), six domains of neurocognition, four domains of social cognition and four domains of metacognition with one another was conducted. The analysis produces the following centrality measures: 1) strength of items within a network according to their sum weighted connections; 2) closeness between items that reflect the distance from a particular item to all others; 3) betweenness which reflect the number of times that an item appears on the shortest path between two other items. Results: A clear differentiation between metacognition, social cognition, neurocognition and symptoms was observed. The only outliers were social cognition attribution, which was close to the symptoms area, and the cognitive symptoms factor that was found close to the neuro-cognition area. The social cognition was found in an "intermediate" area between the metacognition and neurocognition. Metacognition variables were the closest to the symptoms variables. The strongest nodes are: metacognition-self reflectivity, theory of mind measures of social cognition and visual memory. The nodes with the highest closeness measure were self-reflectivity sub-scale of metacognition and theory of mind of social cognition. The node with the highest betweenness measure was metacognition self-reflectivity. Discussion: The centrality of the self-experience in schizophrenia is emphasized in phenomenological, theoretical as well as empirical literature and can be traced back to earlier writing on schizophrenia. Accordingly, a sense of barren or diminished self, problems in self-reflection and self-clarity as well as difficulties in agency and ownership over one's thoughts, feelings and sensations which is necessary for creating meaning were reported and discussed. The current study adds to this body of literature the finding that in a network which includes symptoms, social cognition, neuro cognition and metacognition variables, self-reflection is standing out as being a central connector that has the strongest relationship with other variables. As such it impacts all the network, and interventions targeting metacognitive self-reflection are expected to have secondary effects on additional constructs in the network-i.e additional elements of metacognition, social cognition, neurocognition and symptoms. Background: Cognitive dysfunction is as a hallmark feature of schizophrenia. Antipsychotic medication is effective for treating the positive symptoms of psychosis, but their potential for therapeutic effects on cognition continues to divide researchers. Improvements in clinical symptoms can occur independently of cognitive functioning, whereby typical antipsychotics improve different clinical domains, but have little or no efficacy for improving primary cognitive functions. However, it has been suggested that the second-generation antipsychotic clozapine can improve cognition in schizophrenia. Unusual cases, such as remitted patients who decide to stop taking clozapine, thus represent a unique opportunity to understand the effect of antipsychotic medication on cognition, as described in the case study below. Methods: A 38-year old man suffered severe psychotic episodes at age 19, leading to a diagnosis of treatment-resistant schizophrenia. Clozapine was initiated at age 21, with excellent treatment response and complete remission of positive, negative and depressive symptoms. For the following 16 years, he had a full-time paid job, lived independently and had an ample social circle. For the last five years, he was stable and compliant taking 175 mg of clozapine, with clozapine levels in sub-therapeutic range (between 0.17 and 0.26 mg/L). He had no metabolic syndrome and no oversedation, but complained of hypersalivation and persistent memory problems. He decided, against advice, that medication was no longer needed and requested support for waning off clozapine. A five-month program was subsequently implemented, with 25 mg reductions of clozapine every six weeks. Four enhanced assessments were scheduled after two weeks on stable doses of 125, 75, 25 and 0 mg, respectively, which included the Brief Assessment of Cognition in Schizophrenia (BACS) and the Clinical Global Impression-Schizophrenia scale (CGI-SCH). Results: At each level of clozapine dose, the patient continued to be stable. However, the patient showed impaired cognitive performance at the highest dose of clozapine titration (see T-scores from Table and figure) , with improvements then shown at each level of dose reduction (75 and 25 mg). The final assessment was done after 6 weeks of not taking medication. At this time, he was admitted to hospital for psychotic relapse. Unfortunately, the patient refused to re-initiate clozapine and has remained floridly psychotic for 18 months. Our case suggests that cognitive impairment is dose-dependent with clozapine. As presented, the t-score of the patient at 125 mg was worse than normative data reported for healthy controls (z-score=0.50) and patients with schizophrenia treated with other first-or second generation antipsychotics (z-score=-1.42). However, cognitive performance of the patient was most notably impaired when medication-free. Discussion: The longterm effects of high-dose antipsychotic medication on cognition in patients with schizophrenia are largely unknown. It is also possible that changes in cognitive states are either domain-specific with clozapine. Nonetheless, daily antipsychotic dose and polypharmacy have been shown to predict poor cognitive functioning. The present case is also a reminder that the appropriate long-term maintenance dose of clozapine is poorly understood. As this case suggests, the current recommended therapeutic levels of clozapine (0.35 to 0.50 mg/L) might be unnecessarily high for patients in full remission. Controlled studies are therefore needed to evaluate the potential for cognitive improvements in schizophrenia as a function of reduced clozapine dose, to ensure the optimal delivery needed not just for good clinical but also good cognitive outcome. 
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Background: Aberrant salience is thought to play a role in the development of the symptoms of schizophrenia, but the hypothesis lacks consistent support. Previous research found no relationship in a population sample between two measures of aberrant salience: the self-report Aberrant Salience Inventory (ASI) and the computerised Salience Attribution Task (SAT), which measures implicit (behavioural) and explicit (self-report) aberrant and adaptive salience. We compared the ASI and SAT in individuals with schizophrenia, with anxiety, and with no mental disorder (unaffected). Methods: Individuals with schizophrenia (n = 30), anxiety (n = 33), or unaffected (n = 30) completed the ASI and the SAT. Results: ASI scores were higher in the schizophrenia group than anxiety (t(90) = 2.72, p < .01) and unaffected groups (t (90) = 5.29, p < .001) and higher in the anxiety than unaffected group (t(90) = 2.69, p < .01). SAT explicit adaptive salience scores were lower in the schizophrenia group than the anxiety (t(90) = -3.79, p < .001) and unaffected groups (t(90)= -3.86, p < .001). The schizophrenia group also had higher SAT implicit aberrant salience than the anxiety group (t(90) = 2.57, p < .05) but not the unaffected group (t(90) = 3.75, p = .08); there was no difference between anxiety and control groups (t(90) -0.76, p = .45). Group did not affect SAT explicit aberrant salience (F(2,91) = 0.47, p =.63) or implicit adaptive salience (F(90) = 0.62, p = .54). We found no correlation between the ASI and the SAT (all τ < .218, p > .05). Discussion: Higher ASI scores were associated with, but not unique to, schizophrenia. Reduced SAT explicit adaptive salience was associated with schizophrenia, while SAT implicit aberrant salience scores differed between psychopathologies. Consistent with previous findings, there was no relationship between the ASI and the SAT. The ASI is designed to measure a trait associated with schizophrenia. Conversely, the SAT implicit aberrant salience measures response latency to irrelevant stimuli. The lack of relationship between ASI and SAT may, therefore, be due to construct divergence.
